The nucleotide-binding oligomerization domain-like receptor NLRC5 is involved in IFN-dependent antiviral immune responses
about
Activation of nucleotide oligomerization domain 2 (NOD2) by human cytomegalovirus initiates innate immune responses and restricts virus replicationNLR family member NLRC5 is a transcriptional regulator of MHC class I genesA role for the human nucleotide-binding domain, leucine-rich repeat-containing family member NLRC5 in antiviral responsesUbiquitin in the activation and attenuation of innate antiviral immunityNLRC5, at the Heart of Antigen PresentationRegulation of immune pathways by the NOD-like receptor NLRC5NLRC5: a newly discovered MHC class I transactivator (CITA)Holding the inflammatory system in check: NLRs keep it coolNLRs, inflammasomes, and viral infectionCentral roles of NLRs and inflammasomes in viral infectionNLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-κB signaling pathwaysCutting edge: NLRP12 controls dendritic and myeloid cell migration to affect contact hypersensitivityThe inflammasome NLRs in immunity, inflammation, and associated diseasesAlarmins, inflammasomes and immunity.NLRC5 knockdown in chicken macrophages alters response to LPS and poly (I:C) stimulation.Induction and function of virus-specific CD4+ T cell responses.Investigating the Role of Gene-Gene Interactions in TB Susceptibility.Pharmacologic activation of the innate immune system to prevent respiratory viral infections.Functional Analysis of Chicken IRF7 in Response to dsRNA Analog Poly(I:C) by Integrating Overexpression and KnockdownGenetic Signature of Resistance to White Band Disease in the Caribbean Staghorn Coral Acropora cervicornis.Enhanced TLR-induced NF-κB signaling and type I interferon responses in NLRC5 deficient miceNLRC5 regulates MHC class I antigen presentation in host defense against intracellular pathogens.DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.Regulation of class I major histocompatibility complex (MHC) by nucleotide-binding domain, leucine-rich repeat-containing (NLR) proteins.Engineering macrophages to control the inflammatory response and angiogenesis.Gene expression profiles associated with depression in patients with chronic hepatitis C (CH-C)Bacterial Muramyl Dipeptide (MDP) Restricts Human Cytomegalovirus Replication via an IFN-β-Dependent PathwayCutting edge: impaired MHC class I expression in mice deficient for Nlrc5/class I transactivator.Refractoriness of interferon-beta signaling through NOD1 pathway in mouse respiratory epithelial cells using the anticancer xanthone compoundCutting edge: NLRC5-dependent activation of the inflammasome.NLRC5/MHC class I transactivator is a target for immune evasion in cancer.NLRC5, a promising new entry in tumor immunology.The expanding role of NLRs in antiviral immunity.Functions of NOD-Like Receptors in Human Diseases.Innate sensing of viruses by pattern recognition receptors in birds.The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus.Role of nucleotide-binding oligomerization domain 1 (NOD1) and its variants in human cytomegalovirus control in vitro and in vivo.Reestablishment of p53/Arf and interferon-β pathways mediated by a novel adenoviral vector potentiates antiviral response and immunogenic cell death.Cross-regulation between the IL-1β/IL-18 processing inflammasome and other inflammatory cytokines.Buying time-the immune system determinants of the incubation period to respiratory viruses.
P2860
Q24293059-85BFED1E-C7C6-4CCB-B710-7148F4362C7DQ24338949-9401200B-6896-4670-B0BD-CBE845E3EBCDQ24630474-CE980467-BBE1-4A7B-A2D6-16401EF0AD9FQ26771789-C5CC9AB2-8C0E-4590-BC77-55EB988F3012Q26823400-3A812001-C39F-44D1-8835-B766E01A7E34Q26853152-8E9E2D5C-4DCA-4CC8-932B-FD2E8E992196Q27024182-E904561C-FFC6-46B4-A126-D8CDAC515F15Q28081065-D4ED9BDE-77E9-4199-B66A-526A5B37400BQ28387246-BC8AA1AF-8E7E-403B-8419-9B0A688808B8Q28395291-A00127B2-9A39-49D2-8702-2FC5DD8F7DCFQ28590675-7712286B-0C05-4542-9B16-1683C214A224Q28590726-EF5965BB-5841-4FFC-8E78-6DA60548E66BQ29616025-C8DEF990-8BE1-4018-8078-D9F964A8308BQ33817302-87032303-EF75-450A-AB92-430F3836C1DBQ34188469-0EC9FEE8-C5FA-451D-942E-C23A816C721CQ34856857-9D6F5773-ED9A-4145-96AF-408A76DD99A5Q35616623-AF204857-FAB7-41E3-9FC3-9B44B9A1ABF0Q35692082-4806B405-65DE-45FA-9BA0-B7D6734C4532Q35694778-6583DB30-C82A-47C1-BC9D-5EF789A5B38AQ35897561-413B2841-217B-4AE4-97CA-A6038249B208Q35932378-D70D2228-F4D4-437B-95D1-DAF3CF05226AQ35940044-FD099055-C1F1-4071-8988-8606930CD9EDQ36086311-AF74A17F-6F03-4C57-9078-9F088FF4D043Q36097953-C03DD099-6739-4830-B46D-33A49CD50472Q36372956-3C144688-7C72-4598-8FC2-4D57DBAE5DA8Q36373495-3F42879E-319A-4318-A188-9D5799B38E93Q36528505-82B7B4EF-F195-4EB6-A3BE-E9253D54C3C4Q36626948-62447607-C393-4453-BFC1-FE20DFFAB6A1Q36839796-9DB693A7-7C0C-43DD-B4BE-7B12E9EDAB38Q36893463-87E5CAB2-27E9-42B9-BB21-2438D3E7A26AQ36957315-08BF4BC3-DF76-433C-B6FC-89C3D4DBEEC9Q37108366-9520C856-5454-43D4-89DF-2FD5278CDBD0Q37138886-C7658706-FAE3-4537-A1D8-6BAAD8258CBFQ37231612-93D591C3-036E-4D6D-9C12-C9FCFF49B71BQ37359798-E51DAC84-CD90-4D30-82BF-84CF432BE811Q37395985-EB0ACE1A-8A93-4BC2-96F8-D8FA2570DDD6Q37473694-61D8D355-D0C7-4826-B11D-A195381B85E9Q37710422-4034D64B-2A67-46C0-9B40-BBC4E9BC0E06Q37916934-69DB6CE2-859D-4877-8A81-FC769A9F6F85Q37945196-7ACA559A-1BFB-491A-9067-A78DA0798157
P2860
The nucleotide-binding oligomerization domain-like receptor NLRC5 is involved in IFN-dependent antiviral immune responses
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The nucleotide-binding oligome ...... ent antiviral immune responses
@ast
The nucleotide-binding oligome ...... ent antiviral immune responses
@en
The nucleotide-binding oligome ...... ent antiviral immune responses
@en-gb
The nucleotide-binding oligome ...... ent antiviral immune responses
@nl
type
label
The nucleotide-binding oligome ...... ent antiviral immune responses
@ast
The nucleotide-binding oligome ...... ent antiviral immune responses
@en
The nucleotide-binding oligome ...... ent antiviral immune responses
@en-gb
The nucleotide-binding oligome ...... ent antiviral immune responses
@nl
prefLabel
The nucleotide-binding oligome ...... ent antiviral immune responses
@ast
The nucleotide-binding oligome ...... ent antiviral immune responses
@en
The nucleotide-binding oligome ...... ent antiviral immune responses
@en-gb
The nucleotide-binding oligome ...... ent antiviral immune responses
@nl
P2093
P50
P3181
P356
P1476
The nucleotide-binding oligome ...... ent antiviral immune responses
@en
P2093
Helmut Fickenscher
Joachim Grötzinger
Michael Winkler
Robert Häsler
Simone Lipinski
Stefan Schreiber
Sven Kuenzel
P304
P3181
P356
10.4049/JIMMUNOL.0900557
P407
P577
2010-01-08T00:00:00Z